Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2000
11/30/2000CA2374714A1 Purine derivatives, preparation method and pharmaceutical compositions containing same
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374301A1 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/30/2000CA2371920A1 Niacinamide compositions with reduced tack
11/29/2000EP1055707A1 Autodispersing inverse latex
11/29/2000EP1055668A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/29/2000EP1055665A1 3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives
11/29/2000EP1054899A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON $g(b)-CATENIN, AND THE PRODUCTION AND USE THEREOF
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054886A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054691A1 Skin care compositions
11/29/2000EP1054687A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
11/29/2000EP0809484B1 Cosmetic or pharmaceutical, particularly dermatological, composition containing a bertholletia extract
11/29/2000EP0555205B1 Dna encoding a growth factor specific for epithelial cells
11/29/2000CN1274595A Scenting pellet
11/29/2000CN1274586A Burn and scald treating external-use ointment
11/29/2000CN1058965C New thiophene compounds, process for their preparation and pharmaceutical compositions containing them
11/29/2000CN1058900C Paste for treating face skin ulcer and method for preparing same
11/29/2000CN1058886C Oral medicine for treatment of acne
11/29/2000CN1058881C Oral liquid for health-care and skin-nursing
11/29/2000CN1058869C Chinese traditional medicine of hair lotion and preparing process
11/29/2000CN1058866C Medicinal composition for treating tinea manus and pedis
11/29/2000CN1058865C Cream for treating tinea cruris
11/28/2000US6153649 Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration
11/28/2000US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists
11/28/2000US6153615 Administering nitric oxide synthesis inhibiting amount of dihydrofolate reductase inhibitor, catecholamine replacing non-toxic amount of levodopa with or without carbidopa and serotonin replacing non-toxic amount of l-5-hydroxytryptophane
11/28/2000US6153609 Arylsulfonylamino hydroxamic acid derivatives
11/28/2000US6153605 Useful in treatment or prevention of vitamin d dependent disorders, particularly psoriasis, basal cell carcinomas, disorders of keratinization and keratosis, leukemia, osteoporosis, hyperparathyroidism accompanying renal failure
11/28/2000US6153601 Polyholoside compositions for stimulating the immune system
11/28/2000US6153591 Protecting nervous system following focal ischemia and global ischemia; alzheimer's disease, huntington's disease, prion diseases, parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, alopacia, rheumatoid arthritis
11/28/2000US6153205 Topical application product containing a lipase, a vitamin precursor and a fatty alcohol
11/28/2000CA2309505A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2309475A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2309434A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2267136C Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/27/2000CA2309413A1 Novel detergent compositions with enhanced depositing, conditioning and softness capabilities
11/27/2000CA2309373A1 Novel topical formulations
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070045A1 Ox2 receptor homologs
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070025A1 Methods of using rnase p reaction mechanisms of action
11/23/2000WO2000069884A2 Compositions isolated from skin cells and methods for their use
11/23/2000WO2000069861A1 THIAZOLOPYRIMIDINES USEFUL AS TNFα INHIBITORS
11/23/2000WO2000069860A1 Imidazo-containing heterocyclic compounds, their compositions and uses
11/23/2000WO2000069859A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069846A1 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069820A1 Cyclic amine derivatives and their uses
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069818A1 MORPHOLINO-N-ETHYL ESTER DERIVATIVE OF AN INDOLE sPLA2 INHIBITOR
11/23/2000WO2000069470A2 Improved cellular uptake of bioactive agents
11/23/2000WO2000069449A2 Conditioned cell culture medium compositions and methods of use
11/23/2000WO2000069426A2 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
11/23/2000WO2000069408A1 Methods of regulating the condition of mammalian keratinous tissue
11/23/2000WO2000069404A1 Methods for regulating the condition of mammalian keratinous tissue via topical application of phytosterol compositions
11/23/2000WO2000069277A1 A composition containing carvacrol and thymol for use as a bactericide
11/23/2000WO2000043371A3 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000WO2000043354A3 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000WO2000037502A3 Vascular endothelial cell growth factor antagonists and uses thereof
11/23/2000WO2000037067A9 Sensitizing agents for the treatment of skin lesions
11/23/2000WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/23/2000WO2000031134A9 Regulation of hair follicle morphogenesis based on beta-catenin
11/23/2000WO2000031081A3 Amino- and mercurio-substituted 4',5'-dihydropsoralens and therapeutical uses thereof
11/23/2000WO2000027429A3 Vaccine against papillomatous digital dermatitis (pdd)
11/23/2000WO2000023053A3 Artificial antigen-specific cells and related methods
11/23/2000WO2000021486A9 Prevention of uv-induced functional vitamin a deficiency through use of topically applied retinoid
11/23/2000WO1999061398A3 24-hydroxyvitamin d, analogs and uses thereof
11/23/2000CA2374559A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2374045A1 Compositions isolated from skin cells and methods for their use
11/23/2000CA2373607A1 Cyclic amine derivatives and their uses
11/23/2000CA2373532A1 Morpholino-n-ethyl ester derivative of an indole spla2 inhibitor
11/23/2000CA2373500A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000CA2373194A1 Methods of regulating the condition of mammalian keratinous tissue
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2373158A1 Methods for regulating the condition of mammalian keratinous tissue via topical application of phytosterol compositions
11/23/2000CA2372934A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372549A1 Ox2 receptor homologs
11/23/2000CA2372429A1 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
11/23/2000CA2372426A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000CA2372051A1 Imidazo-containing heterocyclic compounds, their compositions and uses
11/23/2000CA2372044A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
11/23/2000CA2370066A1 Thiazolopyrimidines useful as tnf.alpha. inhibitors
11/23/2000CA2368640A1 A composition containing carvacrol and thymol for use as a bactericide
11/22/2000EP1053989A2 Hydroxydiphenyl ether compounds
11/22/2000EP1053750A1 Use of proteasome-inhibitor for the induction of programmed cell death (apoptosis)
1 ... 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 ... 1065